Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes
Lucy M Hinder1, Kelli M Sas2, Phillipe D O'Brien1
1Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Abstract:
Diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR) contribute to significant morbidity and mortality in diabetes patients. The incidence of these complications is increasing with the diabetes epidemic, and current therapies minimally impact their pathogenesis in type 2 diabetes (T2D). Improved mechanistic understanding of each of the diabetic complications is needed in order to develop disease-modifying treatments for patients. We recently identified fundamental differences in mitochondrial responses of peripheral nerve, kidney, and retinal tissues to T2D in BKS-db/db mice. However, whether these mitochondrial adaptations are the cause or consequence of tissue dysfunction remains unclear. In the current study BKS-db/db mice were treated with the mitochondrial uncoupler, niclosamide ethanolamine (NEN), to determine the effects of mitochondrial uncoupling therapy on T2D, and the pathogenesis of DPN, DKD and DR. Here we report that NEN treatment from 6-24 wk of age had little effect on the development of T2D and diabetic complications. Our data suggest that globally targeting mitochondria with an uncoupling agent is unlikely to provide therapeutic benefit for DPN, DKD, or DR in T2D. These data also highlight the need for further insights into the role of tissue-specific metabolic reprogramming in the pathogenesis of diabetic complications.
Insights
Targeting mitochondria with niclosamide ethanolamine (NEN) did not improve type 2 diabetes (T2D) or its complications, including diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR). This suggests global mitochondrial uncoupling is not a viable therapy for T2D complications.
Area of Science:
- Mitochondrial biology
- Diabetes complications
- Metabolic diseases
Background:
- Diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR) are major causes of morbidity and mortality in type 2 diabetes (T2D).
- Current therapies offer limited impact on the pathogenesis of these T2D complications.
- Tissue-specific mitochondrial adaptations in T2D are known, but their causal role in dysfunction is unclear.
Purpose of the Study:
- To investigate the therapeutic potential of mitochondrial uncoupling using niclosamide ethanolamine (NEN) in T2D.
- To determine the effects of NEN on the development of T2D and its complications (DPN, DKD, DR) in a mouse model.
Main Methods:
- BKS-db/db mice, a model for T2D, were treated with NEN from 6 to 24 weeks of age.
- Evaluated the impact of NEN treatment on T2D progression and the development of DPN, DKD, and DR.
Main Results:
- NEN treatment showed minimal effect on the development of T2D.
- NEN treatment did not significantly alter the progression of DPN, DKD, or DR.
- Global mitochondrial uncoupling did not provide therapeutic benefit for the studied diabetic complications.
Conclusions:
- Targeting mitochondria globally with an uncoupling agent like NEN is unlikely to be an effective therapeutic strategy for DPN, DKD, or DR in T2D.
- Further research is needed to understand tissue-specific metabolic reprogramming in the pathogenesis of diabetic complications.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Animal Mitochondrial Genetics
Hemodialysis II: Procedure and Complications
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

